The study aims at bringing forward an association between type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD) in patients of T2DM with deranged alanine aminotransferase (ALT). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.